Managers / Q1 2025 · view latest →
Samsara BioCapital, LLC
CIK 0001744967 · 628 MIDDLEFIELD ROAD, PALO ALTO, CA, 94301 · (650) 285-4270
Reported Value
$561M
Q1 2025
Positions
37
Filings on Record
32
2019–present window
Filed
May 15, 2025
original filing
Summary
Samsara Biocapital, Llc reported $561M in U.S.-listed holdings across 37 positions for Q1 2025.
The portfolio is heavily concentrated: SRRK alone accounts for 32.2% of reported value.
Compared with Q4 2024, the fund opened 2 new positions and exited 8.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 96.4% · $541M
- Other · 3.1% · $17M
- ADR · 0.5% · $3M
- Equity WRT · 0.0% · $45,667
Quarter-over-Quarter Changes full breakdown →
Holdings — Q1 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.0B | 22 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $969M | 21 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $766M | 27 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $489M | 29 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $561M | 37 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $729M | 43 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $520M | 42 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $478M | 40 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $646M | 39 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $643M | 41 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $327M | 41 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $570M | 47 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $486M | 56 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022REVEALED | $464.6B | 55 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $429M | 56 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $375M | 57 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $397M | 57 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $515M | 51 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $637M | 48 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $810M | 50 | Aug 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $542M | 44 | May 18, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $994M | 43 | Feb 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $359M | 36 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $311M | 32 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $174M | 28 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $209M | 19 | Feb 18, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $147M | 18 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $151M | 21 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $127M | 18 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $104M | 17 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.